Pancreatic cancer surgery entails reduced levels of NK cells with abridged expression of the activating NK cell receptor NKp30. Absolute numbers (A, D) and frequencies (B, E) of CD16⁺ (A, B) and CD56bright (D, E) NK cells in preoperative (pre-op) and postoperative (day 1, days 3–5, and day 28) samples from patients with periampullary cancer and healthy donors (HD). Frequencies of NKp30high-expressing cells among CD16⁺ (C) and CD56bright (F) NK cells (N = 16 for pre-op, N = 15 for day 1, N = 14 days 3–5, and N = 10 for day 28 for A and D and N = 16 for pre-op, day 1 and days 3–5, N = 10 for day 28, N = 10 for HD for B–C and E–F). Preoperative and postoperative samples were compared using mixed-effects analysis followed by Šídák multiple comparison test (P-values indicated by *). HD and cancer samples were compared using Kruskal–Wallis test followed by Dunn multiple comparison test (P-values indicated by #). #, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.
No takes yet. Share an insight, caveat, or question.
Wiktorin et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: